PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D826FA0UX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $20,707
Award facts
- Contract value 100% obligated
- $20,707.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $20,707.34 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 27, 2025, with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation, and performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected based on its demonstrated capability to fulfill federal medical procurement requirements through open competition.
Under this delivery order, AmerisourceBergen will supply pharmaceutical products and medical commodities to support federal healthcare needs, consistent with its broader portfolio of medical supply deliveries to the Defense Health Agency and other government healthcare systems. The company's federal contract awards demonstrate extensive experience delivering a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects AmerisourceBergen's established role as a critical vendor within the DLA's Pharmaceutical Prime Vendor program, which utilizes flexible contract vehicles to ensure reliable pharmaceutical support for military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2D826FA0UX?
SPE2D826FA0UX was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on October 27, 2025.
How much is contract SPE2D826FA0UX worth?
The government has obligated $20,707 on SPE2D826FA0UX.
Is contract SPE2D826FA0UX an order under another contract?
Yes. SPE2D826FA0UX is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA0UX competed?
The extent of competition for SPE2D826FA0UX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award